Resultados de la búsqueda 551-560 of 5478 for treatment resistant depression

  1. Ensayos clínicos - Neurología

    FTLD is a neurodegenerative disorder of the nervous system which there are no approved treatments or cures. The study has two arms: a “longitudinal arm” ...

  2. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  3. Epilepsia - Médicos y departamentos - Mayo Clinic

    Mayo Clinic researchers lead transformative shift toward neurorestorative treatment strategies for most severe forms of epilepsy ... drug-resistant epilepsy ...

  4. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  5. CAR-T Cell therapy expertise at Mayo Clinic Comprehensive Cancer Center (Dr. Munoz)

    Experts at Mayo Clinic Comprehensive Cancer Center use CAR-T cell therapy to treat several types of cancer, including acute lymphoblastic leukemia, ...

  6. Depresión (trastorno depresivo mayor) - Médicos y departamentos - Mayo Clinic

    Departamentos y especialidades. Mayo Clinic tiene uno de los centros médicos más grandes y experimentados en los Estados Unidos, con sedes en Arizona, ...

  7. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  8. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    ... treatment of progressive post-hemorrhagic hydrocephalus in neonates with the ... A Registry for Children Treated with Proton Radiation Therapy.

  9. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of the Pediatric Proton Consortium Registry (PPCR) is to enroll children who have been treated with proton radiation in the United States in ...

  10. Programa de terapia de células T con receptores de antígeno quimérico - Ensayos clínicos

    The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...